katero
Jun 30, 2026

Serena Williams, 44, makes stunning tennis return at Wimbledon

Serena Williams made an emotional return to Wimbledon, competing in singles draw at a tournament for the first time in four years, in front of her family on Tuesday. 

The 44-year-old icon sealed a remarkable comeback to the sport when she took to Centre Court at Wimbledon to face World No 87 Maya Joint. 

The 23-time Grand Slam champion was calm and collected as she strolled confidently out onto the heart of SW19. 

The crowd inside the iconic court let out a raucous round of applause, wildly cheering the tennis legend. Not that Williams would have heard, sporting a pair of pale pink headphones to drown out the noise and stay in the zone. 

There was no chance she could have missed the rupture of cheers minutes later when she claimed the first point of the match on her opponent's serve.  

At just 20 years old, Australian Joint is part of the new generation of female tennis players who have never before faced Williams on the court. 

Serena Williams made her singles comeback on her return to Wimbledon on Tuesday

Serena Williams made her singles comeback on her return to Wimbledon on Tuesday

The legend was supported by her husband Alexis Ohanian and their two daughters

The legend was supported by her husband Alexis Ohanian and their two daughters 

Tuesday's first-round clash marks her return to SW19 for the first time in four years - and after having publicly stepped away from the sport following the 2022 US Open. 

In the time since she evolved away from the sport, Williams has welcomed her second daughter, Adira, with Alexis Ohanian, who was in her box to cheer her on. 

The two-year-old defied Wimbledon's age restrictions for Centre Court to sit alongside her dad and older sister Olympia, eight, and watch her mom compete at SW19 for the first time. 

Wimbledon traditionally enforces an age limit of five and above to attend the show courts. However, acceptations were made for the daughter of a seven-time winner.

Williams' posse of supporters was also joined by her sister Venus and new brother-in-law, Italian actor Andrea Preti, whom Venus wed last year. 

The All England Club had left one women's singles wildcard slot conspicuously unclaimed, and on Sunday it was announced that Serena will test herself against the best players in the world - many of whom are less than half her age - at the event she has won seven times.

The 44-year-old began her comeback to tennis - four years after her last professional match - at the Queen's Club's HSBC Championships, where she won a round before being forced out by an injury to her partner Victoria Mboko.

Williams had previously hinted at a potential return to the grass courts after kicking off her competitive tennis comeback in the doubles draw, where she is already locked in to compete alongside her sister, Venus Williams.

Many will be questioning if the veteran still possesses her titan talent, others may be more focused on the question mark over one particular detail of her preparation -whether Williams has continued to use GLP-1 jabs managed by telehealth company Ro, of which she became a vocal paid spokesperson for last year.

Ohanian sat in Williams' box with Adria, two (left), and Olympic, eight, (right)

Ohanian sat in Williams' box with Adria, two (left), and Olympic, eight, (right) 

Tuesday's first-round clash marks her return to SW19 for the first time in four years

Tuesday's first-round clash marks her return to SW19 for the first time in four years

The seven-time Wimbledon champion's husband Alexis Ohanian sits on the company's board and was an early investor. As recently as this February Williams, the company's celebrity face, featured in a Super Bowl advert for the brand and its Zepbound tirzepatide jab, which is also marketed under the name Mounjaro.

Williams, who is said to have lost close to two and a half stone, or 34 pounds (15kg) using the drug, previously called her challenge to lose weight following the birth of her two children 'the one opponent (she) couldn't beat'.

It remains unclear as to whether Williams has continued to use the drug, which also treats symptoms of diabetes, with her publicist declining to comment when asked by the Atlantic.

But although GLP-1s are not banned by the World Anti-Doping Agency (WADA), they are one of the drugs under ongoing investigation as to whether they might be classed as performance-enhancing in the future.

Although Williams would be the first athlete to publicly use a GLP-1 if she was still using Zepbound, tennis has an existing relationship with weight-loss jabs, with semaglutide Ozempic a surprising sponsor at last year's Canadian Open.

Speaking to Professor Olivier Rabin, WADA's head of science, Daily Mail Sport learned that the organisation's study into the GLP-1s was extended in 2026.

'The WADA List Expert Advisory Group has discussed their status, as well as other substances of the same class,' the statement shared with the Athletic from the agency in June read.

Other posts